Pharmaceutical Business Review
Anonymous User | Login

Sanofi-Aventis Presents New R&D Model Project

Published: 30-Jun-2009

Model aims to transform R&D and increase innovation

Sanofi-Aventis has presented its new R&D model project. The model, which aims to transform R&D and increase innovation, is the first step of the group’s new strategy which was presented in February 2009 by the CEO of Sanofi-Aventis, Christopher Viehbacher.

 

Christopher Viehbacher said: “The objective of this new R&D model is to propose innovative solutions that respond to specific, unmet needs of patients and continue our success in a very competitive international environment.”

 

“It is centered on the real needs of patients, the development of scientific networks and openness toward outside entities to strengthen creativity, and a flexible and entrepreneurial approach to research,” he added.

 

Marc Cluzel, Senior Vice President, Research and Development, Sanofi-Aventis, said: “Tomorrow’s research will be carried out through networks. We will be open to knowledge from outside sources, becoming a key partner. We need to reinvent R&D.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Solutions4Science

Temperature Mapping and Validation Services ...

Exploristics

Innovative Analysis Solutions for Data Exploration, Pharmacogenetics, Biomarkers and Exploratory Sta...

NeuroProof

Screening Services for Pre-Clinical Development of Neuro-Pharmaceuticals and Safety Pharmacology ...

DASGIP

Parallel Bioreactor Systems for the Cultivation of Bacterial, Phototrophic, Animal and Human Cells ...

BioKinetic Europe

Phase I/II Contract Research Organisation ...

Toxikon Europe

CRO Providing Preclinical Safety Studies for the Life Science Community ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

AstraZeneca PLC

AstraZeneca PLC (AstraZeneca) is a leading pharmaceuticals company engaged in the desig ...

Boehringer Ingelheim GmbH

Boehringer Ingelheim GmbH (Boehringer) is a group of companies engaged in the research, ...

Merck & Co., Inc.

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company engaged in ...

Abbott Laboratories

Abbott Laboratories (Abbott) is a global health care company. It is principally engaged ...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address